Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 3Phase 2 1

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

OTHER 5NIH 2

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 3Genitourinary 2

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Recurrence 1Papilloma 1Healthy, no Evidence of Disease 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
3,3'-diindolylmethane × Clear all
NCT02197000 2020-11-12

A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers

Rabin Medical Center

Phase NA Completed
23 enrolled
Breast

Breast Neoplasms

NCT00888654 2018-03-19

Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
41 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT01391689 2017-11-06

Diindolylmethane in Treating Patients With Breast Cancer

University of Arizona

Phase NA Completed
144 enrolled
Breast

Breast Neoplasms

NCT00591305 2017-05-18

New Therapy of Laryngeal Papilloma In Children

Boston University

Phase NA Terminated
1 enrolled 6 charts

Papilloma, Recurrence

NCT00784394 2016-12-29

Diindolylmethane in Preventing Cancer in Healthy Volunteers

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled

Healthy, no Evidence of Disease

NCT00450229 2015-12-04

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
45 enrolled
Genitourinary

Prostatic Neoplasms

NCT01022333 2009-12-01

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

Women's College Hospital

Phase 1 Unknown
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡